This is a summary of the European public assessment report (EPAR) for Memantine ratiopharm. It explains how the European Medicines Agency assessed the medicine to recommend its authorisation in the European Union and its conditions of use. It is not intended to provide practical advice on how to use Memantine ratiopharm. For practical information about using Memantine ratiopharm, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Treatment of patients with moderate to severe Alzheimer’s disease
Therapeutic Area (MeSH)
N/AATC Code
N06DX01
ATC Item
memantine
Pharmacotherapeutic Group
Psychoanaleptics
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| memantine hydrochloride | N/A | 美金刚 |
EMA Name
Memantine ratiopharm
Medicine Name
Memantine ratiopharm
Aliases
N/ANo risk management plan link.
